KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Liabilities and Shareholders Equity: 2017-2025

Historic Liabilities and Shareholders Equity for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to $1.3 billion.

  • Guardant Health's Liabilities and Shareholders Equity fell 17.02% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 billion, marking a year-over-year decrease of 18.08%. This contributed to the annual value of $1.5 billion for FY2024, which is 16.84% down from last year.
  • As of Q3 2025, Guardant Health's Liabilities and Shareholders Equity stood at $1.3 billion, which was down 4.15% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Liabilities and Shareholders Equity registered a high of $2.3 billion during Q1 2021, and its lowest value of $1.3 billion during Q3 2025.
  • For the 3-year period, Guardant Health's Liabilities and Shareholders Equity averaged around $1.6 billion, with its median value being $1.5 billion (2024).
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 147.50% in 2021, then fell by 29.02% in 2023.
  • Quarterly analysis of 5 years shows Guardant Health's Liabilities and Shareholders Equity stood at $2.2 billion in 2021, then dropped by 26.97% to $1.6 billion in 2022, then climbed by 10.96% to $1.8 billion in 2023, then decreased by 16.84% to $1.5 billion in 2024, then dropped by 17.02% to $1.3 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $1.3 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.3 billion for Q1 2025.